1
|
Chen PM, Nguyen DT, Ho JP, Pirastehfar M, Narula R, Rapp K, Agrawal K, Huisa B, Modir R, Meyer D, Hemmen T, Kidwell C, Meyer BC. Factors Influencing Acute Stroke Thrombolytic Treatments in Hispanics In the San Diego Region. Austin J Cerebrovasc Dis Stroke 2018; 5:1074. [PMID: 30148213 PMCID: PMC6103626] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
BACKGROUND Since the introduction of recombinant tissue plasminogen activator (rt-PA) for acute ischemic stroke, rt-PA rate and number of stroke centers have increased. Despite this, studies have shown racial and ethnic disparities in stroke care especially in Black and Hispanic populations. What factors are related to the administration of rt-PA within the Hispanic population has to date been unclear. METHODS We performed a retrospective review of IRB approved, prospectively collected data from the UC San Diego Stroke Registry from 7/2004-7/2016. Patients were included based on the primary diagnosis of Transient Ischemic Attack or Ischemic Stroke. Hispanic vs non-Hispanic patients were compared to assess for overall rt-PA treatment rates and process of care intervals. For the Hispanic cohort itself, demographics and NIHSS scores were assessed to determine why some Hispanics received rt-PA while others were not. RESULTS Overall, 1489 patients (300 Hispanic vs. 1189 non-Hispanic) were included. Comparing Hispanics to non-Hispanics, there was no difference in rt-PA rate (35.3% vs. 33.1%; p=0.49). In rt-PA treated patients, "onset to arrival" interval was higher in Hispanics (1.03 vs. 0.88 hours; p=0.04), while the "arrival to treatment" interval was not different (1.13 vs. 1.02 hours; p=0.07). When looking at Hispanic patients only, there was no difference in baseline characteristics except for initial NIHSS in treated vs. non-treated patients (13.27 vs. 7.24; p<.001). CONCLUSION Our analyses sought to determine the factors important to administration of rt-PA to Hispanic patients. These findings highlight the need for strategies to improve recognition and presentation pathways for Hispanics.
Collapse
Affiliation(s)
- P M Chen
- Department of Neurosciences, Stroke Center, University of California, San Diego, USA
| | - D T Nguyen
- Department of Neurosciences, Stroke Center, University of California, San Diego, USA
| | - J P Ho
- Department of Neurosciences, Stroke Center, University of California, San Diego, USA
| | - M Pirastehfar
- Department of Neurosciences, Stroke Center, University of California, San Diego, USA
| | - R Narula
- Department of Neurosciences, Stroke Center, University of California, San Diego, USA
| | - K Rapp
- Department of Neurosciences, Stroke Center, University of California, San Diego, USA
| | - K Agrawal
- Department of Neurosciences, Stroke Center, University of California, San Diego, USA
| | - B Huisa
- Department of Neurosciences, Stroke Center, University of California, San Diego, USA
| | - R Modir
- Department of Neurosciences, Stroke Center, University of California, San Diego, USA
| | - D Meyer
- Department of Neurosciences, Stroke Center, University of California, San Diego, USA
| | - T Hemmen
- Department of Neurosciences, Stroke Center, University of California, San Diego, USA
| | - C Kidwell
- Department of Neurology, University of Arizona, USA
| | - B C Meyer
- Department of Neurosciences, Stroke Center, University of California, San Diego, USA
| |
Collapse
|
2
|
Nael K, Meshksar A, Ellingson B, Pirastehfar M, Salamon N, Finn P, Liebeskind DS, Villablanca JP. Combined low-dose contrast-enhanced MR angiography and perfusion for acute ischemic stroke at 3T: A more efficient stroke protocol. AJNR Am J Neuroradiol 2014; 35:1078-84. [PMID: 24503557 DOI: 10.3174/ajnr.a3848] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
BACKGROUND AND PURPOSE There is need to improve image acquisition speed for MR imaging in evaluation of patients with acute ischemic stroke. The purpose of this study was to evaluate the feasibility of a 3T MR stroke protocol that combines low-dose contrast-enhanced MRA and dynamic susceptibility contrast perfusion, without additional contrast. METHODS Thirty patients with acute stroke who underwent 3T MR imaging followed by DSA were retrospectively enrolled. TOF-MRA of the neck and brain and 3D contrast-enhanced MRA of the craniocervical arteries were obtained. A total of 0.1 mmol/kg of gadolinium was used for both contrast-enhanced MRA (0.05 mmol/kg) and dynamic susceptibility contrast perfusion (0.05 mmol/kg) (referred to as half-dose). An age-matched control stroke population underwent TOF-MRA and full-dose (0.1 mmol/kg) dynamic susceptibility contrast perfusion. The cervicocranial arteries were divided into 25 segments. Degree of arterial stenosis on contrast-enhanced MRA and TOF-MRA was compared with DSA. Time-to-maximum maps (>6 seconds) were evaluated for image quality and hypoperfusion. Quantitative analysis of arterial input function curves, SNR, and maximum T2* effects were compared between half- and full-dose groups. RESULTS The intermodality agreements (k) for arterial stenosis were 0.89 for DSA/contrast-enhanced MRA and 0.63 for DSA/TOF-MRA. Detection specificity of >50% arterial stenosis was lower for TOF-MRA (89%) versus contrast-enhanced MRA (97%) as the result of overestimation of 10% (39/410) of segments by TOF-MRA. The DWI-perfusion mismatch was identified in both groups with high interobserver agreement (r = 1). There was no significant difference between full width at half maximum of the arterial input function curves (P = .14) or the SNR values (0.6) between the half-dose and full-dose groups. CONCLUSIONS In patients with acute stroke, combined low-dose contrast-enhanced MRA and dynamic susceptibility contrast perfusion at 3T is feasible and results in significant scan time and contrast dose reductions.
Collapse
Affiliation(s)
- K Nael
- From the Department of Medical Imaging (K.N., A.M.), University of Arizona, Tucson, Arizona
| | - A Meshksar
- From the Department of Medical Imaging (K.N., A.M.), University of Arizona, Tucson, Arizona
| | - B Ellingson
- Department of Radiological Sciences (B.E., M.P., N.S., P.F., J.P.V.)
| | - M Pirastehfar
- Department of Radiological Sciences (B.E., M.P., N.S., P.F., J.P.V.)
| | - N Salamon
- Department of Radiological Sciences (B.E., M.P., N.S., P.F., J.P.V.)
| | - P Finn
- Department of Radiological Sciences (B.E., M.P., N.S., P.F., J.P.V.)
| | - D S Liebeskind
- Department of Neurology, Stroke Center (D.S.L.), University of California, Los Angeles, Los Angeles, California
| | - J P Villablanca
- Department of Radiological Sciences (B.E., M.P., N.S., P.F., J.P.V.)
| |
Collapse
|